Surgalign Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 20.55 million compared to USD 27.93 million a year ago. Net loss was USD 7.91 million compared to net income of USD 122.68 million a year ago. Basic loss per share from continuing operations was USD 1.8 compared to USD 10.8 a year ago. Diluted loss per share from continuing operations was USD 1.8 compared to USD 10.8 a year ago.
For the nine months, sales was USD 68.67 million compared to USD 75.56 million a year ago. Net loss was USD 39.29 million compared to net income of USD 66.26 million a year ago. Basic loss per share from continuing operations was USD 8.7 compared to USD 31.2 a year ago. Diluted loss per share from continuing operations was USD 8.7 compared to USD 31.2 a year ago.